MoneyWorks4Me

Anuh Pharma - Quaterly Results

19 May 2023 Evaluate
The company witnessed a 21.97% growth in the revenue at Rs. 1573.10 millions for the quarter ended March 2023 as compared to Rs. 1289.70 millions during the year-ago period.Net profit stood at Rs. 96.23  millions  compared to Rs. 89.25 millions in the corresponding previous quarter,high by 7.82%.The company reported a good operating profit of 152.70 millions compared to 148.99 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1573.10 1289.70 21.97 5274.86 4866.46 8.39 5274.86 4866.46 8.39
Other Income 10.37 10.29 0.78 61.15 51.97 17.66 61.15 51.97 17.66
PBIDT 152.70 148.99 2.49 573.90 520.43 10.27 573.90 520.43 10.27
Interest 0.23 -1.77 -112.99 2.18 9.61 -77.32 2.18 9.61 -77.32
PBDT 152.47 150.76 1.13 571.72 510.82 11.92 571.72 510.82 11.92
Depreciation 24.07 30.07 -19.95 97.00 119.60 -18.90 97.00 119.60 -18.90
PBT 128.40 120.69 6.39 474.72 391.22 21.34 474.72 391.22 21.34
TAX 32.17 31.44 2.32 112.91 85.61 31.89 112.91 85.61 31.89
Deferred Tax -5.93 -4.56 30.04 -8.29 -9.95 -16.68 -8.29 -9.95 -16.68
PAT 96.23 89.25 7.82 361.81 305.61 18.39 361.81 305.61 18.39
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 250.56 0.00
PBIDTM(%) 9.71 11.55 -15.97 10.88 10.69 1.74 10.88 10.69 1.74
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..